About Professor Michael Loebinger

Consultant Respiratory Physician

Lung Health

Sub-specialties: Respiratory Medicine, Bronchiectasis, Non-tuberculous Mycobacteria, Tuberculosis, Respiratory Infections, COVID/Post-COVID syndromes, Breathlessness, General Respiratory Medicine, Asthma, COPD, Lung Health.

Prof Michael Loebinger is a Consultant Respiratory Physician at Royal Brompton, where he leads the lung division and host defence unit. He has particular expertise in bronchiectasis, primary ciliary dyskinesia, chronic infection, host defence abnormalities, and bacterial, fungal and mycobacterial infections. He is Professor of Practice at Imperial and has published over 150 papers and leads global international studies and guidelines.

Overview

Bookings: bookings.lunghealth@onewelbeck.com

Tel: 020 3653 2006

Areas of Expertise

Dr Loebinger treats a range of conditions, including:

Treatments:

  • General Respiratory Medicine

About Professor Michael Loebinger

Professor Michael Loebinger is a Consultant Respiratory Physician here at OneWelbeck Lung Health. He also leads the lung division at Royal Brompton and Harefield Hospitals. He specialises in respiratory infection and also leads the host defence unit, which is one of the most respected respiratory infection units in the world, looking after some of the largest global cohorts of patients with bronchiectasis, non tuberculous mycobacteria (NTM) and fungal disease. He has helped shape international clinical practice and co-chaired the British Thoracic Society (BTS) bronchiectasis guidelines and co-wrote the BTS NTM and European respiratory Society (ERS) bronchiectasis guidelines. He is a founding member of the UK and European clinical and research bronchiectasis and NTM networks, and leads global multicentre clinical trials.

He has an active research programme, which has produced over 150 publications, media interest and grant awards and he was awarded Professor of Practice (Respiratory Medicine) at Imperial College in 2018. He is also a very keen footballer having represented Cambridge and Oxford University 1st teams in fixtures which have included English Premier League reserve teams, a passion that he is also living vicariously through his children.

Additional Information

Clinical Posts:

  • Professor Michael Loebinger MA FRCP PhD
  • Director of the Lung Division, Clinical Director of Laboratory Medicine, Deputy Medical Director, Consultant Respiratory Medicine
  • Royal Brompton & Harefield Hospitals
  • Royal Brompton Hospital, Sydney Street, London, SW3 6NP
  • Guys and St Thomas’ NHS Foundation Trust
  • Professor of Practice (Respiratory Medicine)
  • National Heart and Lung Institute
  • Imperial College London

Memberships:
  • Fellow of the Royal College of Physicians
  • European Respiratory Society - Chair Infection Group
  • British Thoracic Society
  • European Research Network

Awards:

  • 2023 National Clinical Impact Award
  • 2019 National Clinical Excellence Award
  • 2018 Award for innovation in non-tuberculous Mycobacteria, European Respiratory Society (ERS)
  • 2010 Prize and Bursary, Medical Research Society (MRS).
  • 2009 Young Investigator of the Year Winner, Royal Society of Medicine (RSM).
  • Young Investigator of the Year Winner, British Association of Lung Research.
  • Best of all American Thoracic Society Scholars.
  • International Trainee Fellowship, American Thoracic Society.
  • Young Investigator of the Year Winner, ERS.
  • 2008 Young Investigator of the Year Winner, British Thoracic Society.
  • 2006 Medical Research Council Clinical Research Training Fellowship.

Research Highlights

Include journals such as New England Journal of Medicine, Lancet Respiratory Medicine and Nature Communications:

Book a consultation

Jun 2024

MON TUE WED THU FRI SAT SUN

Appointments available on this day

Click any unavailable day to check availability with similar consultants

Prof Michael Loebinger is a Consultant Respiratory Physician at Royal Brompton, where he leads the lung division and host defence unit. He has particular expertise in bronchiectasis, primary ciliary dyskinesia, chronic infection, host defence abnormalities, and bacterial, fungal and mycobacterial infections. He is Professor of Practice at Imperial and has published over 150 papers and leads global international studies and guidelines.